Infliximab FDA Link

A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE.

Also Known As:

Remicade; Inflectra; Infliximab-abda; Infliximab-dyyb; MAb cA2; Monoclonal Antibody cA2; Renflexis; Antibody cA2, Monoclonal; Infliximab abda; Infliximab dyyb; cA2, Monoclonal Antibody

Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Blood Proteins: 12679
    - Serum Globulins: 555
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Infliximab: 9505
    - Immunoproteins: 43
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Infliximab: 9505
  - Globulins: 3119
    - Serum Globulins: 555
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Infliximab: 9505

Ratanaporn Pornkul Selected Research

Ratanaporn Pornkul Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure